{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:46:57Z","timestamp":1792788417731,"version":"4.5.0"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Union\u2019s Horizon 2020","award":["No. 847721, PREMSTEM"],"award-info":[{"award-number":["No. 847721, PREMSTEM"]}]},{"name":"European Union\u2019s Horizon 2020","award":["No. 847721, PREMSTEM"],"award-info":[{"award-number":["No. 847721, PREMSTEM"]}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2022_EKEA.43"],"award-info":[{"award-number":["2022_EKEA.43"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt; BMFTR","award":["01GL2401A"],"award-info":[{"award-number":["01GL2401A"]}],"id":[{"id":"https:\/\/ror.org\/04pz7b180","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>MSC-based therapies have emerged as a highly promising approach for two of the most devastating consequences of perinatal insults such as extreme prematurity and perinatal asphyxia: bronchopulmonary dysplasia (BPD) and neonatal brain injury. Both conditions share a common pathophysiological basis of inflammation, oxidative stress, and disrupted progenitor cell function in critical windows of organ development. Exogenous MSC act primarily through their secretome, releasing extracellular vesicles, growth factors, and immunomodulatory mediators that attenuate injury and support organ development. Despite compelling preclinical evidence and early clinical feasibility and safety data, neither indication has yet achieved definitive proof of therapeutic efficacy in adequately powered randomised trials. This review summarises the current state of knowledge for MSC-based therapies for neonatal chronic lung disease and subsequently for brain injury, highlighting shared mechanisms, organ-specific considerations, and the path towards clinical implementation.<\/jats:p>","DOI":"10.1186\/s40348-026-00262-z","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:21:29Z","timestamp":1791361289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mesenchymal Stem Cell (MSC)-based therapies for neonatal lung and brain injury \u2013 one size fits all?"],"prefix":"10.1186","volume":"13","author":[{"given":"U.","family":"Felderhoff-M\u00fcser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Herz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bendix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Behnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"3","key":"262_CR1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00441-016-2545-0","volume":"367","author":"JC Schittny","year":"2017","unstructured":"Schittny JC (2017) Development of the lung. Cell Tissue Res 367(3):427\u2013444. https:\/\/doi.org\/10.1007\/s00441-016-2545-0","journal-title":"Cell Tissue Res"},{"issue":"6","key":"262_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1089\/scd.2019.0116","volume":"29","author":"M O\u2019Reilly","year":"2020","unstructured":"O\u2019Reilly M, Mobius MA, Vadivel A, Ionescu L, Fung M, Eaton F et al (2020) Late Rescue Therapy with Cord-Derived Mesenchymal Stromal Cells for Established Lung Injury in Experimental Bronchopulmonary Dysplasia. Stem Cells Dev 29(6):364\u2013371. https:\/\/doi.org\/10.1089\/scd.2019.0116","journal-title":"Stem Cells Dev"},{"issue":"3","key":"262_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.tins.2020.10.017","volume":"44","author":"M Chini","year":"2021","unstructured":"Chini M, Hanganu-Opatz IL (2021) Prefrontal Cortex Development in Health and Disease: Lessons from Rodents and Humans. Trends Neurosci 44(3):227\u2013240. https:\/\/doi.org\/10.1016\/j.tins.2020.10.017","journal-title":"Trends Neurosci"},{"key":"262_CR4","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.3389\/fimmu.2018.02186","volume":"9","author":"S Schepanski","year":"2018","unstructured":"Schepanski S, Buss C, Hanganu-Opatz IL, Arck PC (2018) Prenatal Immune and Endocrine Modulators of Offspring\u2019s Brain Development and Cognitive Functions Later in Life. Front Immunol 9:2186. https:\/\/doi.org\/10.3389\/fimmu.2018.02186","journal-title":"Front Immunol"},{"key":"262_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","volume":"106\u2013107","author":"BD Semple","year":"2013","unstructured":"Semple BD, Blomgren K, Gimlin K, Ferriero DM, Noble-Haeusslein LJ (2013) Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species. Prog Neurobiol 106\u2013107:1\u201316. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.04.001","journal-title":"Prog Neurobiol"},{"key":"262_CR6","doi-asserted-by":"publisher","unstructured":"Obst S, Serdar M, Herz J, Kempe K, Assili M, Rizazad M et al (2025) A Novel Model for Simultaneous Evaluation of Hyperoxia-Mediated Brain and Lung Injury in Neonatal Rats. Cells 14(6). https:\/\/doi.org\/10.3390\/cells14060443","DOI":"10.3390\/cells14060443"},{"issue":"11","key":"262_CR7","first-page":"1692","volume":"27","author":"ZF Tian","year":"2007","unstructured":"Tian ZF, Du J, Wang B, Hong XY, Feng ZC (2007) [Intravenous infusion of rat bone marrow-derived mesenchymal stem cells ameliorates hyperoxia-induced lung injury in neonatal rats]. Nan Fang Yi Ke Da Xue Xue Bao 27(11):1692\u20131695","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"2","key":"262_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/stcltm\/szab011","volume":"11","author":"M Benny","year":"2022","unstructured":"Benny M, Courchia B, Shrager S, Sharma M, Chen P, Duara J et al (2022) Comparative Effects of Bone Marrow-derived Versus Umbilical Cord Tissue Mesenchymal Stem Cells in an Experimental Model of Bronchopulmonary Dysplasia. Stem Cells Transl Med 11(2):189\u2013199. https:\/\/doi.org\/10.1093\/stcltm\/szab011","journal-title":"Stem Cells Transl Med"},{"key":"262_CR9","doi-asserted-by":"publisher","first-page":"1802976","DOI":"10.1155\/2020\/1802976","volume":"2020","author":"M Kim","year":"2020","unstructured":"Kim M, Kwon JH, Bae YK, Kim GH, Um S, Ha J et al (2020) Soluble PTX3 of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Attenuates Hyperoxic Lung Injury by Activating Macrophage Polarization in Neonatal Rat Model. Stem Cells Int 2020:1802976. https:\/\/doi.org\/10.1155\/2020\/1802976","journal-title":"Stem Cells Int"},{"key":"262_CR10","doi-asserted-by":"publisher","unstructured":"Kwon JH, Kim M, Bae YK, Kim GH, Choi SJ, Oh W et al (2019) Decorin Secreted by Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Induces Macrophage Polarization via CD44 to Repair Hyperoxic Lung Injury. Int J Mol Sci 20(19). https:\/\/doi.org\/10.3390\/ijms20194815","DOI":"10.3390\/ijms20194815"},{"issue":"3","key":"262_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.bbi.2009.10.017","volume":"24","author":"CT van Velthoven","year":"2010","unstructured":"van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ (2010) Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun 24(3):387\u2013393. https:\/\/doi.org\/10.1016\/j.bbi.2009.10.017","journal-title":"Brain Behav Immun"},{"key":"262_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bbi.2018.02.006","volume":"70","author":"J Herz","year":"2018","unstructured":"Herz J, Koster C, Reinboth BS, Dzietko M, Hansen W, Sabir H et al (2018) Interaction between hypothermia and delayed mesenchymal stem cell therapy in neonatal hypoxic-ischemic brain injury. Brain Behav Immun 70:118\u2013130. https:\/\/doi.org\/10.1016\/j.bbi.2018.02.006","journal-title":"Brain Behav Immun"},{"issue":"6","key":"262_CR13","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/ana.78000","volume":"98","author":"CGM de Theije","year":"2025","unstructured":"de Theije CGM, De Palma ST, Vaes JEG, Dallaglio K, Volpi G, Ardigo D et al (2025) Intranasal Wharton\u2019s Jelly-Derived Mesenchymal Stem Cell Therapy, Alone or in Conjunction With Therapeutic Hypothermia, Alleviates Neonatal Hypoxic-Ischemic Brain Injury in Mice. Ann Neurol 98(6):1380\u20131394. https:\/\/doi.org\/10.1002\/ana.78000","journal-title":"Ann Neurol"},{"issue":"16","key":"262_CR14","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1089\/scd.2016.0027","volume":"25","author":"B Oppliger","year":"2016","unstructured":"Oppliger B, Joerger-Messerli M, Mueller M, Reinhart U, Schneider P, Surbek DV et al (2016) Intranasal Delivery of Umbilical Cord-Derived Mesenchymal Stem Cells Preserves Myelination in Perinatal Brain Damage. Stem Cells Dev 25(16):1234\u20131242. https:\/\/doi.org\/10.1089\/scd.2016.0027","journal-title":"Stem Cells Dev"},{"issue":"6","key":"262_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jcyt.2020.10.005","volume":"23","author":"NJ Robertson","year":"2021","unstructured":"Robertson NJ, Meehan C, Martinello KA, Avdic-Belltheus A, Boggini T, Mutshiya T et al (2021) Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxia. Cytotherapy 23(6):521\u2013535. https:\/\/doi.org\/10.1016\/j.jcyt.2020.10.005","journal-title":"Cytotherapy"},{"issue":"3","key":"262_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/pr.2012.71","volume":"72","author":"ES Kim","year":"2012","unstructured":"Kim ES, Ahn SY, Im GH, Sung DK, Park YR, Choi SH et al (2012) Human umbilical cord blood-derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats. Pediatr Res 72(3):277\u2013284. https:\/\/doi.org\/10.1038\/pr.2012.71","journal-title":"Pediatr Res"},{"issue":"4","key":"262_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/scd.2016.0108","volume":"26","author":"M Mueller","year":"2017","unstructured":"Mueller M, Oppliger B, Joerger-Messerli M, Reinhart U, Barnea E, Paidas M et al (2017) Wharton\u2019s Jelly Mesenchymal Stem Cells Protect the Immature Brain in Rats and Modulate Cell Fate. Stem Cells Dev 26(4):239\u2013248. https:\/\/doi.org\/10.1089\/scd.2016.0108","journal-title":"Stem Cells Dev"},{"issue":"5","key":"262_CR18","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.jpeds.2013.12.011","volume":"164","author":"YS Chang","year":"2014","unstructured":"Chang YS, Ahn SY, Yoo HS, Sung SI, Choi SJ, Oh WI et al (2014) Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr 164(5):966\u2013972 e6. https:\/\/doi.org\/10.1016\/j.jpeds.2013.12.011","journal-title":"J Pediatr"},{"issue":"8","key":"262_CR19","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/sctm.20-0330","volume":"10","author":"SY Ahn","year":"2021","unstructured":"Ahn SY, Chang YS, Lee MH, Sung SI, Lee BS, Kim KS et al (2021) Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial. Stem Cells Transl Med 10(8):1129\u20131137. https:\/\/doi.org\/10.1002\/sctm.20-0330","journal-title":"Stem Cells Transl Med"},{"key":"262_CR20","doi-asserted-by":"publisher","first-page":"101844","DOI":"10.1016\/j.eclinm.2023.101844","volume":"57","author":"R Zhuxiao","year":"2023","unstructured":"Zhuxiao R, Fang X, Wei W, Shumei Y, Jianlan W, Qiuping L et al (2023) Prevention for moderate or severe BPD with intravenous infusion of autologous cord blood mononuclear cells in very preterm infants-a prospective non-randomized placebo-controlled trial and two-year follow up outcomes. EClinicalMedicine 57:101844. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101844","journal-title":"EClinicalMedicine"},{"issue":"5","key":"262_CR21","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jpeds.2013.11.036","volume":"164","author":"CM Cotten","year":"2014","unstructured":"Cotten CM, Murtha AP, Goldberg RN, Grotegut CA, Smith PB, Goldstein RF et al (2014) Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J Pediatr 164(5):973\u20139e1. https:\/\/doi.org\/10.1016\/j.jpeds.2013.11.036","journal-title":"J Pediatr"},{"issue":"12","key":"262_CR22","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/sctm.17-0219","volume":"7","author":"SY Ahn","year":"2018","unstructured":"Ahn SY, Chang YS, Sung SI, Park WS (2018) Mesenchymal Stem Cells for Severe Intraventricular Hemorrhage in Preterm Infants: Phase I Dose-Escalation Clinical Trial. Stem Cells Transl Med 7(12):847\u2013856. https:\/\/doi.org\/10.1002\/sctm.17-0219","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"262_CR23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S1474-4422(22)00117-X","volume":"21","author":"LM Baak","year":"2022","unstructured":"Baak LM, Wagenaar N, van der Aa NE, Groenendaal F, Dudink J, Tataranno ML et al (2022) Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study. Lancet Neurol 21(6):528\u2013536. https:\/\/doi.org\/10.1016\/S1474-4422(22)00117-X","journal-title":"Lancet Neurol"},{"issue":"9","key":"262_CR24","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1161\/STROKEAHA.125.050786","volume":"56","author":"N Wagenaar","year":"2025","unstructured":"Wagenaar N, Baak LM, van der Aa NE, Groenendaal F, Dudink J, Tataranno ML et al (2025) Perinatal Arterial Stroke Treated With Stromal Cells Intranasally: 2-Year Safety and Neurodevelopment. Stroke 56(9):2410\u20132418. https:\/\/doi.org\/10.1161\/STROKEAHA.125.050786","journal-title":"Stroke"},{"issue":"5","key":"262_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3346\/jkms.2015.30.5.509","volume":"30","author":"SY Ahn","year":"2015","unstructured":"Ahn SY, Chang YS, Park WS (2015) Stem cell therapy for bronchopulmonary dysplasia: bench to bedside translation. J Korean Med Sci 30(5):509\u2013513. https:\/\/doi.org\/10.3346\/jkms.2015.30.5.509","journal-title":"J Korean Med Sci"},{"issue":"1","key":"262_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41390-022-02208-3","volume":"95","author":"V Lehnerer","year":"2024","unstructured":"Lehnerer V, Roidl A, Romantsik O, Guzman R, Wellmann S, Bruschettini M (2024) Mesenchymal stem cell therapy in perinatal arterial ischemic stroke: systematic review of preclinical studies. Pediatr Res 95(1):18\u201333. https:\/\/doi.org\/10.1038\/s41390-022-02208-3","journal-title":"Pediatr Res"},{"issue":"11","key":"262_CR27","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1164\/rccm.200902-0242OC","volume":"180","author":"M Aslam","year":"2009","unstructured":"Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, Mitsialis SA et al (2009) Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 180(11):1122\u20131130. https:\/\/doi.org\/10.1164\/rccm.200902-0242OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"262_CR28","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1164\/rccm.200902-0179OC","volume":"180","author":"T van Haaften","year":"2009","unstructured":"van Haaften T, Byrne R, Bonnet S, Rochefort GY, Akabutu J, Bouchentouf M et al (2009) Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 180(11):1131\u20131142. https:\/\/doi.org\/10.1164\/rccm.200902-0179OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"262_CR29","doi-asserted-by":"publisher","first-page":"e0135574","DOI":"10.1371\/journal.pone.0135574","volume":"10","author":"DK Sung","year":"2015","unstructured":"Sung DK, Chang YS, Ahn SY, Sung SI, Yoo HS, Choi SJ et al (2015) Optimal Route for Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation to Protect Against Neonatal Hyperoxic Lung Injury: Gene Expression Profiles and Histopathology. PLoS ONE 10(8):e0135574. https:\/\/doi.org\/10.1371\/journal.pone.0135574","journal-title":"PLoS ONE"},{"issue":"3","key":"262_CR30","doi-asserted-by":"publisher","first-page":"e0120893","DOI":"10.1371\/journal.pone.0120893","volume":"10","author":"WS Park","year":"2015","unstructured":"Park WS, Sung SI, Ahn SY, Yoo HS, Sung DK, Im GH et al (2015) Hypothermia augments neuroprotective activity of mesenchymal stem cells for neonatal hypoxic-ischemic encephalopathy. PLoS ONE 10(3):e0120893. https:\/\/doi.org\/10.1371\/journal.pone.0120893","journal-title":"PLoS ONE"},{"issue":"8","key":"262_CR31","doi-asserted-by":"publisher","first-page":"e73031","DOI":"10.1371\/journal.pone.0073031","volume":"8","author":"RK Jellema","year":"2013","unstructured":"Jellema RK, Wolfs TG, Lima Passos V, Zwanenburg A, Ophelders DR, Kuypers E et al (2013) Mesenchymal stem cells induce T-cell tolerance and protect the preterm brain after global hypoxia-ischemia. PLoS ONE 8(8):e73031. https:\/\/doi.org\/10.1371\/journal.pone.0073031","journal-title":"PLoS ONE"},{"issue":"1","key":"262_CR32","doi-asserted-by":"publisher","first-page":"7665","DOI":"10.1038\/s41598-018-25902-x","volume":"8","author":"SY Ahn","year":"2018","unstructured":"Ahn SY, Chang YS, Sung DK, Sung SI, Park WS (2018) Hypothermia broadens the therapeutic time window of mesenchymal stem cell transplantation for severe neonatal hypoxic ischemic encephalopathy. Sci Rep 8(1):7665. https:\/\/doi.org\/10.1038\/s41598-018-25902-x","journal-title":"Sci Rep"},{"issue":"11","key":"262_CR33","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/thorax-2022-219622","volume":"78","author":"SY Ahn","year":"2023","unstructured":"Ahn SY, Chang YS, Lee MH, Sung S, Kim AR, Park WS (2023) Five-year follow-up of phase II trial of stromal cells for bronchopulmonary dysplasia. Thorax 78(11):1105\u20131110. https:\/\/doi.org\/10.1136\/thorax-2022-219622","journal-title":"Thorax"},{"issue":"2","key":"262_CR34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.gendis.2022.02.001","volume":"10","author":"Y Xia","year":"2023","unstructured":"Xia Y, Lang T, Niu Y, Wu X, Zhou O, Dai J et al (2023) Phase I trial of human umbilical cord-derived mesenchymal stem cells for treatment of severe bronchopulmonary dysplasia. Genes Dis 10(2):521\u2013530. https:\/\/doi.org\/10.1016\/j.gendis.2022.02.001","journal-title":"Genes Dis"},{"issue":"6","key":"262_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/stcltm\/szad027","volume":"12","author":"CM Cotten","year":"2023","unstructured":"Cotten CM, Fisher K, Malcolm W, Gustafson KE, Cheatham L, Marion A et al (2023) A Pilot Phase I Trial of Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Neonates With Hypoxic-Ischemic Encephalopathy. Stem Cells Transl Med 12(6):355\u2013364. https:\/\/doi.org\/10.1093\/stcltm\/szad027","journal-title":"Stem Cells Transl Med"},{"key":"262_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jpeds.2017.08.041","volume":"190","author":"CM Alvira","year":"2017","unstructured":"Alvira CM, Morty RE (2017) Can We Understand the Pathobiology of Bronchopulmonary Dysplasia? J Pediatr 190:27\u201337. https:\/\/doi.org\/10.1016\/j.jpeds.2017.08.041","journal-title":"J Pediatr"},{"key":"262_CR37","doi-asserted-by":"publisher","unstructured":"Goetz MJ, Kremer S, Behnke J, Staude B, Shahzad T, Holzfurtner L et al (2021) MSC Based Therapies to Prevent or Treat BPD-A Narrative Review on Advances and Ongoing Challenges. Int J Mol Sci 22(3). https:\/\/doi.org\/10.3390\/ijms22031138","DOI":"10.3390\/ijms22031138"},{"issue":"1","key":"262_CR38","doi-asserted-by":"publisher","first-page":"e52419","DOI":"10.1371\/journal.pone.0052419","volume":"8","author":"YS Chang","year":"2013","unstructured":"Chang YS, Choi SJ, Ahn SY, Sung DK, Sung SI, Yoo HS et al (2013) Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury. PLoS ONE 8(1):e52419. https:\/\/doi.org\/10.1371\/journal.pone.0052419","journal-title":"PLoS ONE"},{"issue":"1","key":"262_CR39","doi-asserted-by":"publisher","first-page":"e51253","DOI":"10.1371\/journal.pone.0051253","volume":"8","author":"V Donega","year":"2013","unstructured":"Donega V, van Velthoven CT, Nijboer CH, van Bel F, Kas MJ, Kavelaars A et al (2013) Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement. PLoS ONE 8(1):e51253. https:\/\/doi.org\/10.1371\/journal.pone.0051253","journal-title":"PLoS ONE"},{"issue":"1","key":"262_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12974-025-03593-2","volume":"23","author":"C Bokobza","year":"2025","unstructured":"Bokobza C, Reda C, Nair S, Guenoun D, Rocha-Ferreira E, Faivre V et al (2025) A systematic scoring system to optimise the testing of neurotherapeutics in models of perinatal brain injury, with an applied case study of human umbilical-cord MSC. J Neuroinflammation 23(1):3. https:\/\/doi.org\/10.1186\/s12974-025-03593-2","journal-title":"J Neuroinflammation"},{"issue":"1","key":"262_CR41","doi-asserted-by":"publisher","first-page":"35031","DOI":"10.1038\/s41598-025-22330-6","volume":"15","author":"MJ Goetz","year":"2025","unstructured":"Goetz MJ, Behnke J, Oehmke F, Holzfurtner L, Korte P, Rivetti S et al (2025) Phenotype disruption of umbilical cord derived MSC by cyclic mechanical stretch and hyperoxia mediated by p21. Sci Rep 15(1):35031. https:\/\/doi.org\/10.1038\/s41598-025-22330-6","journal-title":"Sci Rep"},{"issue":"5","key":"262_CR42","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1165\/rcmb.2018-0358OC","volume":"60","author":"MA Mobius","year":"2019","unstructured":"Mobius MA, Freund D, Vadivel A, Koss S, McConaghy S, Ohls RK et al (2019) Oxygen Disrupts Human Fetal Lung Mesenchymal Cells. Implications for Bronchopulmonary Dysplasia. Am J Respir Cell Mol Biol 60(5):592\u2013600. https:\/\/doi.org\/10.1165\/rcmb.2018-0358OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"262_CR43","doi-asserted-by":"publisher","first-page":"L694","DOI":"10.1152\/ajplung.00355.2023","volume":"327","author":"J Behnke","year":"2024","unstructured":"Behnke J, Goetz MJ, Holzfurtner L, Korte P, Weiss A, Shahzad T et al (2024) Senescence of lung mesenchymal stem cells of preterm infants by cyclic stretch and hyperoxia via p21. Am J Physiol Lung Cell Mol Physiol 327(5):L694\u2013L711. https:\/\/doi.org\/10.1152\/ajplung.00355.2023","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"262_CR44","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00441-019-03145-0","volume":"380","author":"A Schmiedl","year":"2020","unstructured":"Schmiedl A, Bokel K, Huhn V, Ionescu L, Zscheppang K, Dammann CEL (2020) Bone marrow stem cells accelerate lung maturation and prevent the LPS-induced delay of morphological and functional fetal lung development in the presence of ErbB4. Cell Tissue Res 380(3):547\u2013564. https:\/\/doi.org\/10.1007\/s00441-019-03145-0","journal-title":"Cell Tissue Res"},{"issue":"7","key":"262_CR45","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1053\/j.semperi.2018.09.007","volume":"42","author":"F Lesage","year":"2018","unstructured":"Lesage F, Thebaud B (2018) Nanotherapies for micropreemies: Stem cells and the secretome in bronchopulmonary dysplasia. Semin Perinatol 42(7):453\u2013458. https:\/\/doi.org\/10.1053\/j.semperi.2018.09.007","journal-title":"Semin Perinatol"},{"issue":"8","key":"262_CR46","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jcyt.2015.03.008","volume":"17","author":"SY Ahn","year":"2015","unstructured":"Ahn SY, Chang YS, Sung DK, Yoo HS, Sung SI, Choi SJ et al (2015) Cell type-dependent variation in paracrine potency determines therapeutic efficacy against neonatal hyperoxic lung injury. Cytotherapy 17(8):1025\u20131035. https:\/\/doi.org\/10.1016\/j.jcyt.2015.03.008","journal-title":"Cytotherapy"},{"issue":"1","key":"262_CR47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1164\/rccm.201705-0925OC","volume":"197","author":"GR Willis","year":"2018","unstructured":"Willis GR, Fernandez-Gonzalez A, Anastas J, Vitali SH, Liu X, Ericsson M et al (2018) Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation. Am J Respir Crit Care Med 197(1):104\u2013116. https:\/\/doi.org\/10.1164\/rccm.201705-0925OC","journal-title":"Am J Respir Crit Care Med"},{"key":"262_CR48","doi-asserted-by":"publisher","unstructured":"Ahn SY, Sung DK, Chang YS, Park WS (2022) Intratracheal Transplantation of Mesenchymal Stem Cells Attenuates Hyperoxia-Induced Microbial Dysbiosis in the Lungs, Brain, and Gut in Newborn Rats. Int J Mol Sci 23(12). https:\/\/doi.org\/10.3390\/ijms23126601","DOI":"10.3390\/ijms23126601"},{"issue":"5","key":"262_CR49","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.pedneo.2020.05.012","volume":"61","author":"HC Chou","year":"2020","unstructured":"Chou HC, Chen CM (2020) Human placenta-derived mesenchymal stem cells attenuate established hyperoxia-induced lung injury in newborn rats. Pediatr Neonatol 61(5):498\u2013505. https:\/\/doi.org\/10.1016\/j.pedneo.2020.05.012","journal-title":"Pediatr Neonatol"},{"issue":"9","key":"262_CR50","doi-asserted-by":"publisher","first-page":"L829","DOI":"10.1152\/ajplung.00347.2011","volume":"302","author":"KA Tropea","year":"2012","unstructured":"Tropea KA, Leder E, Aslam M, Lau AN, Raiser DM, Lee JH et al (2012) Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 302(9):L829\u2013L837. https:\/\/doi.org\/10.1152\/ajplung.00347.2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"10","key":"262_CR51","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.5966\/sctm.2015-0337","volume":"5","author":"EF Cahill","year":"2016","unstructured":"Cahill EF, Kennelly H, Carty F, Mahon BP, English K (2016) Hepatocyte Growth Factor Is Required for Mesenchymal Stromal Cell Protection Against Bleomycin-Induced Pulmonary Fibrosis. Stem Cells Transl Med 5(10):1307\u20131318. https:\/\/doi.org\/10.5966\/sctm.2015-0337","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"262_CR52","doi-asserted-by":"publisher","first-page":"151724","DOI":"10.1016\/j.semperi.2023.151724","volume":"47","author":"B Thebaud","year":"2023","unstructured":"Thebaud B (2023) Stem cell therapies for neonatal lung diseases: Are we there yet? Semin Perinatol 47(3):151724. https:\/\/doi.org\/10.1016\/j.semperi.2023.151724","journal-title":"Semin Perinatol"},{"issue":"6","key":"262_CR53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3345\/kjp.2014.57.6.251","volume":"57","author":"SY Ahn","year":"2014","unstructured":"Ahn SY, Chang YS, Park WS (2014) Mesenchymal stem cells transplantation for neuroprotection in preterm infants with severe intraventricular hemorrhage. Korean J Pediatr 57(6):251\u2013256. https:\/\/doi.org\/10.3345\/kjp.2014.57.6.251","journal-title":"Korean J Pediatr"},{"issue":"3","key":"262_CR54","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000490943","volume":"40","author":"MCB Paton","year":"2018","unstructured":"Paton MCB, Allison BJ, Li J, Fahey MC, Sutherland AE, Nitsos I et al (2018) Human Umbilical Cord Blood Therapy Protects Cerebral White Matter from Systemic LPS Exposure in Preterm Fetal Sheep. Dev Neurosci 40(3):258\u2013270. https:\/\/doi.org\/10.1159\/000490943","journal-title":"Dev Neurosci"},{"issue":"3","key":"262_CR55","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s41390-024-03412-z","volume":"97","author":"LW Wang","year":"2025","unstructured":"Wang LW, Hsiung CW, Chang CP, Lin MT, Chen SJ (2025) Neuroserpin normalization by mesenchymal stem cell therapy after encephalopathy of prematurity in neonatal rats. Pediatr Res 97(3):1199\u20131208. https:\/\/doi.org\/10.1038\/s41390-024-03412-z","journal-title":"Pediatr Res"},{"key":"262_CR56","doi-asserted-by":"publisher","unstructured":"Wang C, Xu QQ, Zhang SJ, Zhu YP (2026) Human umbilical cord mesenchymal stem cells alleviate hypoxic-ischemia-induced white-matter injury in neonatal rats by regulating polarization of microglia. Sci Rep 16(1). https:\/\/doi.org\/10.1038\/s41598-026-42445-8","DOI":"10.1038\/s41598-026-42445-8"},{"issue":"5","key":"262_CR57","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1161\/STROKEAHA.111.000326","volume":"44","author":"CT van Velthoven","year":"2013","unstructured":"van Velthoven CT, Sheldon RA, Kavelaars A, Derugin N, Vexler ZS, Willemen HL et al (2013) Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke 44(5):1426\u20131432. https:\/\/doi.org\/10.1161\/STROKEAHA.111.000326","journal-title":"Stroke"},{"key":"262_CR58","doi-asserted-by":"publisher","unstructured":"Serdar M, Kempe K, Herz J, Ricci F, Felderhoff-Muser U, Bendix I (2026) Human Mesenchymal Stromal Cells Attenuate Hyperoxia-Induced Cellular Impairment of Immature Oligodendrocyte and Neurons. Cells 15(16). https:\/\/doi.org\/10.3390\/cells15161493","DOI":"10.3390\/cells15161493"},{"issue":"1\u20132","key":"262_CR59","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/pr.2017.256","volume":"83","author":"GR Willis","year":"2018","unstructured":"Willis GR, Mitsialis SA, Kourembanas S (2018) Good things come in small packages: application of exosome-based therapeutics in neonatal lung injury. Pediatr Res 83(1\u20132):298\u2013307. https:\/\/doi.org\/10.1038\/pr.2017.256","journal-title":"Pediatr Res"},{"issue":"8","key":"262_CR60","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/stcltm\/szac041","volume":"11","author":"M Sharma","year":"2022","unstructured":"Sharma M, Bellio MA, Benny M, Kulandavelu S, Chen P, Janjindamai C et al (2022) Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension. Stem Cells Transl Med 11(8):828\u2013840. https:\/\/doi.org\/10.1093\/stcltm\/szac041","journal-title":"Stem Cells Transl Med"},{"issue":"12","key":"262_CR61","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1164\/rccm.202102-0329OC","volume":"204","author":"GR Willis","year":"2021","unstructured":"Willis GR, Reis M, Gheinani AH, Fernandez-Gonzalez A, Taglauer ES, Yeung V et al (2021) Extracellular Vesicles Protect the Neonatal Lung from Hyperoxic Injury through the Epigenetic and Transcriptomic Reprogramming of Myeloid Cells. Am J Respir Crit Care Med 204(12):1418\u20131432. https:\/\/doi.org\/10.1164\/rccm.202102-0329OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"262_CR62","doi-asserted-by":"publisher","first-page":"L688","DOI":"10.1152\/ajplung.00148.2020","volume":"320","author":"A Porzionato","year":"2021","unstructured":"Porzionato A, Zaramella P, Dedja A, Guidolin D, Bonadies L, Macchi V et al (2021) Intratracheal administration of mesenchymal stem cell-derived extracellular vesicles reduces lung injuries in a chronic rat model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 320(5):L688\u2013L704. https:\/\/doi.org\/10.1152\/ajplung.00148.2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"262_CR63","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41232-023-00274-6","volume":"43","author":"N Labusek","year":"2023","unstructured":"Labusek N, Mouloud Y, Koster C, Diesterbeck E, Tertel T, Wiek C et al (2023) Extracellular vesicles from immortalized mesenchymal stromal cells protect against neonatal hypoxic-ischemic brain injury. Inflamm Regen 43(1):24. https:\/\/doi.org\/10.1186\/s41232-023-00274-6","journal-title":"Inflamm Regen"},{"issue":"1","key":"262_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10571-025-01540-6","volume":"45","author":"X Zhang","year":"2025","unstructured":"Zhang X, Zhang Y, Peng X, Yang L, Miao J, Yue Y et al (2025) Targeting Neuroinflammation in Preterm White Matter Injury: Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes. Cell Mol Neurobiol 45(1):23. https:\/\/doi.org\/10.1007\/s10571-025-01540-6","journal-title":"Cell Mol Neurobiol"},{"key":"262_CR65","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbi.2016.11.011","volume":"60","author":"K Drommelschmidt","year":"2017","unstructured":"Drommelschmidt K, Serdar M, Bendix I, Herz J, Bertling F, Prager S et al (2017) Mesenchymal stem cell-derived extracellular vesicles ameliorate inflammation-induced preterm brain injury. Brain Behav Immun 60:220\u2013232. https:\/\/doi.org\/10.1016\/j.bbi.2016.11.011","journal-title":"Brain Behav Immun"},{"key":"262_CR66","doi-asserted-by":"publisher","unstructured":"Gussenhoven R, Klein L, Ophelders D, Habets DHJ, Giebel B, Kramer BW et al (2019) Annexin A1 as Neuroprotective Determinant for Blood-Brain Barrier Integrity in Neonatal Hypoxic-Ischemic Encephalopathy. J Clin Med 8(2). https:\/\/doi.org\/10.3390\/jcm8020137","DOI":"10.3390\/jcm8020137"},{"key":"262_CR67","doi-asserted-by":"publisher","unstructured":"Thomi G, Joerger-Messerli M, Haesler V, Muri L, Surbek D, Schoeberlein A (2019) Intranasally Administered Exosomes from Umbilical Cord Stem Cells Have Preventive Neuroprotective Effects and Contribute to Functional Recovery after Perinatal Brain Injury. Cells 8(8). https:\/\/doi.org\/10.3390\/cells8080855","DOI":"10.3390\/cells8080855"},{"issue":"7","key":"262_CR68","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.17305\/bb.2024.10706","volume":"25","author":"S Xiao","year":"2025","unstructured":"Xiao S, Lv Y, Hou X, Qu S (2025) hUC-MSC extracellular vesicles protect against hypoxic-ischemic brain injury by promoting NLRP3 ubiquitination. Biomol Biomed 25(7):1553\u20131570. https:\/\/doi.org\/10.17305\/bb.2024.10706","journal-title":"Biomol Biomed"},{"issue":"1","key":"262_CR69","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-023-02961-0","volume":"20","author":"N Labusek","year":"2023","unstructured":"Labusek N, Ghari P, Mouloud Y, Koster C, Diesterbeck E, Hadamitzky M et al (2023) Hypothermia combined with extracellular vesicles from clonally expanded immortalized mesenchymal stromal cells improves neurodevelopmental impairment in neonatal hypoxic-ischemic brain injury. J Neuroinflammation 20(1):280. https:\/\/doi.org\/10.1186\/s12974-023-02961-0","journal-title":"J Neuroinflammation"},{"issue":"e2","key":"262_CR70","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jpeds.2017.02.061","volume":"185","author":"SY Ahn","year":"2017","unstructured":"Ahn SY, Chang YS, Kim JH, Sung SI, Park WS (2017) Two-Year Follow-Up Outcomes of Premature Infants Enrolled in the Phase I Trial of Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia. J Pediatr 185(e2):49\u201354. https:\/\/doi.org\/10.1016\/j.jpeds.2017.02.061","journal-title":"J Pediatr"},{"issue":"3","key":"262_CR71","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41390-025-03856-x","volume":"98","author":"MCB Paton","year":"2025","unstructured":"Paton MCB, Benders M, Blatch-Williams R, Dallimore E, Edwards A, Elwood N et al (2025) Updates on neonatal cell and novel therapeutics: Proceedings of the Second Neonatal Cell Therapies Symposium (2024). Pediatr Res 98(3):777\u2013785. https:\/\/doi.org\/10.1038\/s41390-025-03856-x","journal-title":"Pediatr Res"},{"key":"262_CR72","doi-asserted-by":"publisher","first-page":"105492","DOI":"10.1016\/j.ebiom.2024.105492","volume":"111","author":"L Zhou","year":"2025","unstructured":"Zhou L, McDonald CA, Yawno T, Razak A, Connelly K, Novak I et al (2025) Feasibility and safety of autologous cord blood derived cell administration in extremely preterm infants: a single-centre, open-label, single-arm, phase I trial (CORD-SaFe study). EBioMedicine 111:105492. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105492","journal-title":"EBioMedicine"},{"issue":"1","key":"262_CR73","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00381-025-06931-0","volume":"41","author":"PK Panda","year":"2025","unstructured":"Panda PK, Kasinathan A, Panda P, Dawman L, Gupta A, Malik VS et al (2025) Stem cell therapy in neonates with hypoxic-ischemic encephalopathy: a systematic review and meta-analysis. Childs Nerv Syst 41(1):265. https:\/\/doi.org\/10.1007\/s00381-025-06931-0","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"262_CR74","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41390-024-03471-2","volume":"97","author":"H Saneh","year":"2025","unstructured":"Saneh H, Wanczyk H, Walker J, Finck C (2025) Stem cell-derived extracellular vesicles: a potential intervention for Bronchopulmonary Dysplasia. Pediatr Res 97(2):497\u2013509. https:\/\/doi.org\/10.1038\/s41390-024-03471-2","journal-title":"Pediatr Res"},{"issue":"7","key":"262_CR75","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jcyt.2025.03.505","volume":"27","author":"B Giebel","year":"2025","unstructured":"Giebel B, Lim SK (2025) Overcoming challenges in MSC-sEV therapeutics: insights and advances after a decade of research. Cytotherapy 27(7):843\u2013848. https:\/\/doi.org\/10.1016\/j.jcyt.2025.03.505","journal-title":"Cytotherapy"},{"issue":"2","key":"262_CR76","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/MOP.0b013e3283423e6b","volume":"23","author":"AH Jobe","year":"2011","unstructured":"Jobe AH (2011) The new bronchopulmonary dysplasia. Curr Opin Pediatr 23(2):167\u2013172. https:\/\/doi.org\/10.1097\/MOP.0b013e3283423e6b","journal-title":"Curr Opin Pediatr"},{"issue":"7","key":"262_CR77","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","volume":"163","author":"AH Jobe","year":"2001","unstructured":"Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163(7):1723\u20131729. https:\/\/doi.org\/10.1164\/ajrccm.163.7.2011060","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"262_CR78","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.chest.2025.11.046","volume":"169","author":"B Staude","year":"2026","unstructured":"Staude B, Torchin H, Maier RF, Fenton AC, Jarreau PH, Mazela J et al (2026) Factors Influencing Unit-Level Differences in Prevalence of Prematurity-Associated Bronchopulmonary Dysplasia in a European Cohort: An Observational Study. Chest 169(5):1298\u20131310. https:\/\/doi.org\/10.1016\/j.chest.2025.11.046","journal-title":"Chest"},{"key":"262_CR79","doi-asserted-by":"publisher","unstructured":"Choi Y, Rekers L, Dong Y, Holzfurtner L, Goetz MJ, Shahzad T et al (2021) Oxygen Toxicity to the Immature Lung-Part I: Pathomechanistic Understanding and Preclinical Perspectives. Int J Mol Sci 22(20). https:\/\/doi.org\/10.3390\/ijms222011006","DOI":"10.3390\/ijms222011006"},{"key":"262_CR80","doi-asserted-by":"publisher","unstructured":"Dong Y, Rivetti S, Lingampally A, Tacke S, Kojonazarov B, Bellusci S et al (2022) Insights into the Black Box of Intra-Amniotic Infection and Its Impact on the Premature Lung: From Clinical and Preclinical Perspectives. Int J Mol Sci 23(17). https:\/\/doi.org\/10.3390\/ijms23179792","DOI":"10.3390\/ijms23179792"},{"issue":"1","key":"262_CR81","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40348-022-00137-z","volume":"9","author":"L Holzfurtner","year":"2022","unstructured":"Holzfurtner L, Shahzad T, Dong Y, Rekers L, Selting A, Staude B et al (2022) When inflammation meets lung development-an update on the pathogenesis of bronchopulmonary dysplasia. Mol Cell Pediatr 9(1):7. https:\/\/doi.org\/10.1186\/s40348-022-00137-z","journal-title":"Mol Cell Pediatr"},{"issue":"1","key":"262_CR82","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-019-0127-7","volume":"5","author":"B Thebaud","year":"2019","unstructured":"Thebaud B, Goss KN, Laughon M, Whitsett JA, Abman SH, Steinhorn RH et al (2019) Bronchopulmonary dysplasia. Nat Rev Dis Primers 5(1):78. https:\/\/doi.org\/10.1038\/s41572-019-0127-7","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"262_CR83","doi-asserted-by":"publisher","first-page":"L1099","DOI":"10.1152\/ajplung.00217.2007","volume":"293","author":"RD Bland","year":"2007","unstructured":"Bland RD, Mokres LM, Ertsey R, Jacobson BE, Jiang S, Rabinovitch M et al (2007) Mechanical ventilation with 40% oxygen reduces pulmonary expression of genes that regulate lung development and impairs alveolar septation in newborn mice. Am J Physiol Lung Cell Mol Physiol 293(5):L1099\u2013L1110. https:\/\/doi.org\/10.1152\/ajplung.00217.2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"262_CR84","doi-asserted-by":"publisher","first-page":"L231","DOI":"10.1152\/ajplung.00342.2013","volume":"307","author":"AP Popova","year":"2014","unstructured":"Popova AP, Bentley JK, Cui TX, Richardson MN, Linn MJ, Lei J et al (2014) Reduced platelet-derived growth factor receptor expression is a primary feature of human bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 307(3):L231\u2013L239. https:\/\/doi.org\/10.1152\/ajplung.00342.2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"262_CR85","doi-asserted-by":"publisher","first-page":"L735","DOI":"10.1152\/ajplung.00347.2009","volume":"298","author":"AP Popova","year":"2010","unstructured":"Popova AP, Bozyk PD, Goldsmith AM, Linn MJ, Lei J, Bentley JK et al (2010) Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells. Am J Physiol Lung Cell Mol Physiol 298(6):L735\u2013L743. https:\/\/doi.org\/10.1152\/ajplung.00347.2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"262_CR86","doi-asserted-by":"publisher","first-page":"L87","DOI":"10.1152\/ajplung.00505.2017","volume":"315","author":"T Reicherzer","year":"2018","unstructured":"Reicherzer T, Haffner S, Shahzad T, Gronbach J, Mysliwietz J, Hubener C et al (2018) Activation of the NF-kappaB pathway alters the phenotype of MSCs in the tracheal aspirates of preterm infants with severe BPD. Am J Physiol Lung Cell Mol Physiol 315(1):L87\u2013L101. https:\/\/doi.org\/10.1152\/ajplung.00505.2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"12","key":"262_CR87","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1002\/sctm.17-0126","volume":"6","author":"S Augustine","year":"2017","unstructured":"Augustine S, Avey MT, Harrison B, Locke T, Ghannad M, Moher D et al (2017) Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical Studies. Stem Cells Transl Med 6(12):2079\u20132093. https:\/\/doi.org\/10.1002\/sctm.17-0126","journal-title":"Stem Cells Transl Med"},{"issue":"13","key":"262_CR88","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1089\/ars.2013.5781","volume":"21","author":"JJ Collins","year":"2014","unstructured":"Collins JJ, Thebaud B (2014) Lung mesenchymal stromal cells in development and disease: to serve and protect? Antioxid Redox Signal 21(13):1849\u20131862. https:\/\/doi.org\/10.1089\/ars.2013.5781","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"262_CR89","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41390-020-0758-0","volume":"88","author":"M Rudiger","year":"2020","unstructured":"Rudiger M, Kirpalani H, Steinhorn R, Davis JM, Thebaud B (2020) How to introduce MSC-based therapy for the developing lung safely into clinical care? Pediatr Res 88(3):365\u2013368. https:\/\/doi.org\/10.1038\/s41390-020-0758-0","journal-title":"Pediatr Res"},{"issue":"2","key":"262_CR90","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4103\/2045-8932.97603","volume":"2","author":"G Hansmann","year":"2012","unstructured":"Hansmann G, Fernandez-Gonzalez A, Aslam M, Vitali SH, Martin T, Mitsialis SA et al (2012) Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension. Pulm Circ 2(2):170\u2013181. https:\/\/doi.org\/10.4103\/2045-8932.97603","journal-title":"Pulm Circ"},{"issue":"10","key":"262_CR91","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/1440-1681.12604","volume":"43","author":"HC Chou","year":"2016","unstructured":"Chou HC, Lin W, Chen CM (2016) Human mesenchymal stem cells attenuate pulmonary hypertension induced by prenatal lipopolysaccharide treatment in rats. Clin Exp Pharmacol Physiol 43(10):906\u2013914. https:\/\/doi.org\/10.1111\/1440-1681.12604","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"262_CR92","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/mt.2015.44","volume":"23","author":"S Rani","year":"2015","unstructured":"Rani S, Ryan AE, Griffin MD, Ritter T (2015) Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications. Mol Ther 23(5):812\u2013823. https:\/\/doi.org\/10.1038\/mt.2015.44","journal-title":"Mol Ther"},{"issue":"5","key":"262_CR93","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1136\/thoraxjnl-2012-202323","volume":"68","author":"M Pierro","year":"2013","unstructured":"Pierro M, Ionescu L, Montemurro T, Vadivel A, Weissmann G, Oudit G et al (2013) Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax 68(5):475\u2013484. https:\/\/doi.org\/10.1136\/thoraxjnl-2012-202323","journal-title":"Thorax"},{"issue":"2","key":"262_CR94","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/stcltm\/szac088","volume":"12","author":"MA Mobius","year":"2023","unstructured":"Mobius MA, Seidner SR, McCurnin DC, Menschner L, Furboter-Behnert I, Schonfeld J et al (2023) Prophylactic Administration of Mesenchymal Stromal Cells Does Not Prevent Arrested Lung Development in Extremely Premature-Born Non-Human Primates. Stem Cells Transl Med 12(2):97\u2013111. https:\/\/doi.org\/10.1093\/stcltm\/szac088","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"262_CR95","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/sctm.20-0281","volume":"10","author":"EK Baker","year":"2021","unstructured":"Baker EK, Wallace EM, Davis PG, Malhotra A, Jacobs SE, Hooper SB et al (2021) A protocol for cell therapy infusion in neonates. Stem Cells Transl Med 10(5):773\u2013780. https:\/\/doi.org\/10.1002\/sctm.20-0281","journal-title":"Stem Cells Transl Med"},{"issue":"9","key":"262_CR96","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/sctm.18-0079","volume":"7","author":"R Lim","year":"2018","unstructured":"Lim R, Malhotra A, Tan J, Chan ST, Lau S, Zhu D et al (2018) First-In-Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study. Stem Cells Transl Med 7(9):628\u2013635. https:\/\/doi.org\/10.1002\/sctm.18-0079","journal-title":"Stem Cells Transl Med"},{"issue":"7","key":"262_CR97","doi-asserted-by":"publisher","first-page":"e2521158","DOI":"10.1001\/jamanetworkopen.2025.21158","volume":"8","author":"L Zhou","year":"2025","unstructured":"Zhou L, Razak A, McDonald CA, Yawno T, McHugh DT, Whiteley G et al (2025) Early Neurodevelopment of Extremely Preterm Infants Administered Autologous Cord Blood Cell Therapy: Secondary Analysis of a Nonrandomized Clinical Trial. JAMA Netw Open 8(7):e2521158. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.21158","journal-title":"JAMA Netw Open"},{"issue":"7","key":"262_CR98","doi-asserted-by":"publisher","first-page":"e112385","DOI":"10.1136\/bmjopen-2025-112385","volume":"16","author":"L Renesme","year":"2026","unstructured":"Renesme L, Ferretti E, Horth C, Grimwood R, Da Sylva L, Olson V et al (2026) Helping Underdeveloped Lungs with Cells (HULC-2): mesenchymal stromal cells in extreme preterm infants at risk of developing bronchopulmonary dysplasia - a study protocol of a phase 2 multicentre double blind randomised controlled trial in Canada. BMJ Open 16(7):e112385. https:\/\/doi.org\/10.1136\/bmjopen-2025-112385","journal-title":"BMJ Open"},{"key":"262_CR99","doi-asserted-by":"publisher","first-page":"101545","DOI":"10.1016\/j.eclinm.2022.101545","volume":"51","author":"W Yao","year":"2022","unstructured":"Yao W, Dong H, Qi J, Zhang Y, Shi L (2022) Safety and efficacy of mesenchymal stem cells in severe\/critical patients with COVID-19: A systematic review and meta-analysis. EClinicalMedicine 51:101545. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101545","journal-title":"EClinicalMedicine"},{"issue":"1","key":"262_CR100","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13054-022-04287-4","volume":"27","author":"F Wang","year":"2023","unstructured":"Wang F, Li Y, Wang B, Li J, Peng Z (2023) The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials. Crit Care 27(1):31. https:\/\/doi.org\/10.1186\/s13054-022-04287-4","journal-title":"Crit Care"},{"key":"262_CR101","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jpeds.2020.01.070","volume":"222","author":"EA Jensen","year":"2020","unstructured":"Jensen EA, Roberts RS, Schmidt B (2020) Drugs to Prevent Bronchopulmonary Dysplasia: Effect of Baseline Risk on the Number Needed to Treat. J Pediatr 222:244\u2013247. https:\/\/doi.org\/10.1016\/j.jpeds.2020.01.070","journal-title":"J Pediatr"},{"issue":"4","key":"262_CR102","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1159\/000121453","volume":"93","author":"B Schmidt","year":"2008","unstructured":"Schmidt B, Roberts R, Millar D, Kirpalani H (2008) Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants. Neonatology 93(4):284\u2013287. https:\/\/doi.org\/10.1159\/000121453","journal-title":"Neonatology"},{"issue":"11","key":"262_CR103","doi-asserted-by":"publisher","first-page":"CD011932","DOI":"10.1002\/14651858.CD011932.pub2","volume":"11","author":"M Pierro","year":"2017","unstructured":"Pierro M, Thebaud B, Soll R (2017) Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev 11(11):CD011932. https:\/\/doi.org\/10.1002\/14651858.CD011932.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"262_CR104","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamapediatrics.2014.3269","volume":"169","author":"M Douglas-Escobar","year":"2015","unstructured":"Douglas-Escobar M, Weiss MD (2015) Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr 169(4):397\u2013403. https:\/\/doi.org\/10.1001\/jamapediatrics.2014.3269","journal-title":"JAMA Pediatr"},{"issue":"1","key":"262_CR105","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1474-4422(08)70294-1","volume":"8","author":"JJ Volpe","year":"2009","unstructured":"Volpe JJ (2009) Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 8(1):110\u2013124. https:\/\/doi.org\/10.1016\/S1474-4422(08)70294-1","journal-title":"Lancet Neurol"},{"issue":"3","key":"262_CR106","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00401-017-1718-6","volume":"134","author":"SA Back","year":"2017","unstructured":"Back SA (2017) White matter injury in the preterm infant: pathology and mechanisms. Acta Neuropathol 134(3):331\u2013349. https:\/\/doi.org\/10.1007\/s00401-017-1718-6","journal-title":"Acta Neuropathol"},{"issue":"6","key":"262_CR107","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S1474-4422(12)70058-3","volume":"11","author":"B Fleiss","year":"2012","unstructured":"Fleiss B, Gressens P (2012) Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy? Lancet Neurol 11(6):556\u2013566. https:\/\/doi.org\/10.1016\/S1474-4422(12)70058-3","journal-title":"Lancet Neurol"},{"issue":"4","key":"262_CR108","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ijdevneu.2011.02.012","volume":"29","author":"JJ Volpe","year":"2011","unstructured":"Volpe JJ, Kinney HC, Jensen FE, Rosenberg PA (2011) The developing oligodendrocyte: key cellular target in brain injury in the premature infant. Int J Dev Neurosci 29(4):423\u2013440. https:\/\/doi.org\/10.1016\/j.ijdevneu.2011.02.012","journal-title":"Int J Dev Neurosci"},{"issue":"1","key":"262_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1203\/PDR.0b013e3181c1b176","volume":"67","author":"P Ballabh","year":"2010","unstructured":"Ballabh P (2010) Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res 67(1):1\u20138. https:\/\/doi.org\/10.1203\/PDR.0b013e3181c1b176","journal-title":"Pediatr Res"},{"issue":"9","key":"262_CR110","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1177\/0883073809337920","volume":"24","author":"AM Kaindl","year":"2009","unstructured":"Kaindl AM, Favrais G, Gressens P (2009) Molecular mechanisms involved in injury to the preterm brain. J Child Neurol 24(9):1112\u20131118. https:\/\/doi.org\/10.1177\/0883073809337920","journal-title":"J Child Neurol"},{"issue":"6","key":"262_CR111","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.earlhumdev.2010.05.010","volume":"86","author":"JJ Kurinczuk","year":"2010","unstructured":"Kurinczuk JJ, White-Koning M, Badawi N (2010) Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev 86(6):329\u2013338. https:\/\/doi.org\/10.1016\/j.earlhumdev.2010.05.010","journal-title":"Early Hum Dev"},{"issue":"1","key":"262_CR112","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/pr.2013.206","volume":"74","author":"AC Lee","year":"2013","unstructured":"Lee AC, Kozuki N, Blencowe H, Vos T, Bahalim A, Darmstadt GL et al (2013) Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990. Pediatr Res 74(1):50\u201372. https:\/\/doi.org\/10.1038\/pr.2013.206","journal-title":"Pediatr Res"},{"issue":"19","key":"262_CR113","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1056\/NEJMra041996","volume":"351","author":"DM Ferriero","year":"2004","unstructured":"Ferriero DM (2004) Neonatal brain injury. N Engl J Med 351(19):1985\u20131995. https:\/\/doi.org\/10.1056\/NEJMra041996","journal-title":"N Engl J Med"},{"issue":"1","key":"262_CR114","doi-asserted-by":"publisher","first-page":"CD003311","DOI":"10.1002\/14651858.CD003311.pub3","volume":"2013","author":"SE Jacobs","year":"2013","unstructured":"Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG (2013) Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2013(1):CD003311. https:\/\/doi.org\/10.1002\/14651858.CD003311.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"262_CR115","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrneurol.2015.13","volume":"11","author":"H Hagberg","year":"2015","unstructured":"Hagberg H, Mallard C, Ferriero DM, Vannucci SJ, Levison SW, Vexler ZS et al (2015) The role of inflammation in perinatal brain injury. Nat Rev Neurol 11(4):192\u2013208. https:\/\/doi.org\/10.1038\/nrneurol.2015.13","journal-title":"Nat Rev Neurol"},{"key":"262_CR116","doi-asserted-by":"publisher","first-page":"601176","DOI":"10.3389\/fncel.2020.601176","volume":"14","author":"N Kaminski","year":"2020","unstructured":"Kaminski N, Koster C, Mouloud Y, Borger V, Felderhoff-Muser U, Bendix I et al (2020) Mesenchymal Stromal Cell-Derived Extracellular Vesicles Reduce Neuroinflammation, Promote Neural Cell Proliferation and Improve Oligodendrocyte Maturation in Neonatal Hypoxic-Ischemic Brain Injury. Front Cell Neurosci 14:601176. https:\/\/doi.org\/10.3389\/fncel.2020.601176","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"262_CR117","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.nbd.2004.04.003","volume":"16","author":"JM Plane","year":"2004","unstructured":"Plane JM, Liu R, Wang TW, Silverstein FS, Parent JM (2004) Neonatal hypoxic-ischemic injury increases forebrain subventricular zone neurogenesis in the mouse. Neurobiol Dis 16(3):585\u2013595. https:\/\/doi.org\/10.1016\/j.nbd.2004.04.003","journal-title":"Neurobiol Dis"},{"key":"262_CR118","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbi.2015.10.004","volume":"52","author":"M Serdar","year":"2016","unstructured":"Serdar M, Herz J, Kempe K, Lumpe K, Reinboth BS, Sizonenko SV et al (2016) Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia. Brain Behav Immun 52:106\u2013119. https:\/\/doi.org\/10.1016\/j.bbi.2015.10.004","journal-title":"Brain Behav Immun"},{"issue":"1","key":"262_CR119","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12974-025-03389-4","volume":"22","author":"M Serdar","year":"2025","unstructured":"Serdar M, Walther KA, Gallert M, Kempe K, Obst S, Labusek N et al (2025) Prenatal inflammation exacerbates hyperoxia-induced neonatal brain injury. J Neuroinflammation 22(1):57. https:\/\/doi.org\/10.1186\/s12974-025-03389-4","journal-title":"J Neuroinflammation"},{"issue":"7","key":"262_CR120","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/01.WCB.0000123906.17746.00","volume":"24","author":"MJ Romanko","year":"2004","unstructured":"Romanko MJ, Rothstein RP, Levison SW (2004) Neural stem cells in the subventricular zone are resilient to hypoxia\/ischemia whereas progenitors are vulnerable. J Cereb Blood Flow Metab 24(7):814\u2013825. https:\/\/doi.org\/10.1097\/01.WCB.0000123906.17746.00","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4 Pt 2","key":"262_CR121","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/pr.2011.64","volume":"71","author":"CT van Velthoven","year":"2012","unstructured":"van Velthoven CT, Kavelaars A, Heijnen CJ (2012) Mesenchymal stem cells as a treatment for neonatal ischemic brain damage. Pediatr Res 71(4 Pt 2):474\u2013481. https:\/\/doi.org\/10.1038\/pr.2011.64","journal-title":"Pediatr Res"},{"issue":"10","key":"262_CR122","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.5966\/sctm.2015-0078","volume":"4","author":"TR Doeppner","year":"2015","unstructured":"Doeppner TR, Herz J, Gorgens A, Schlechter J, Ludwig AK, Radtke S et al (2015) Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression. Stem Cells Transl Med 4(10):1131\u20131143. https:\/\/doi.org\/10.5966\/sctm.2015-0078","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"262_CR123","doi-asserted-by":"publisher","first-page":"754","DOI":"10.5966\/sctm.2015-0197","volume":"5","author":"DR Ophelders","year":"2016","unstructured":"Ophelders DR, Wolfs TG, Jellema RK, Zwanenburg A, Andriessen P, Delhaas T et al (2016) Mesenchymal Stromal Cell-Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia-Ischemia. Stem Cells Transl Med 5(6):754\u2013763. https:\/\/doi.org\/10.5966\/sctm.2015-0197","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"262_CR124","doi-asserted-by":"publisher","first-page":"151726","DOI":"10.1016\/j.semperi.2023.151726","volume":"47","author":"SY Ahn","year":"2023","unstructured":"Ahn SY, Chang YS, Park WS (2023) Stem cells for neonatal brain injury - Lessons from the bench. Semin Perinatol 47(3):151726. https:\/\/doi.org\/10.1016\/j.semperi.2023.151726","journal-title":"Semin Perinatol"},{"key":"262_CR125","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3389\/fphys.2019.00540","volume":"10","author":"JEG Vaes","year":"2019","unstructured":"Vaes JEG, Vink MA, de Theije CGM, Hoebeek FE, Benders M, Nijboer CHA (2019) The Potential of Stem Cell Therapy to Repair White Matter Injury in Preterm Infants: Lessons Learned From Experimental Models. Front Physiol 10:540. https:\/\/doi.org\/10.3389\/fphys.2019.00540","journal-title":"Front Physiol"},{"issue":"5","key":"262_CR126","doi-asserted-by":"publisher","first-page":"151929","DOI":"10.1016\/j.semperi.2024.151929","volume":"48","author":"A Mintoft","year":"2024","unstructured":"Mintoft A, Vallatos A, Robertson NJ (2024) Mesenchymal Stromal Cell therapy for Hypoxic Ischemic Encephalopathy: Future directions for combination therapy with hypothermia and\/or melatonin. Semin Perinatol 48(5):151929. https:\/\/doi.org\/10.1016\/j.semperi.2024.151929","journal-title":"Semin Perinatol"},{"issue":"4","key":"262_CR127","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.resuscitation.2013.12.006","volume":"85","author":"D Osredkar","year":"2014","unstructured":"Osredkar D, Thoresen M, Maes E, Flatebo T, Elstad M, Sabir H (2014) Hypothermia is not neuroprotective after infection-sensitized neonatal hypoxic-ischemic brain injury. Resuscitation 85(4):567\u2013572. https:\/\/doi.org\/10.1016\/j.resuscitation.2013.12.006","journal-title":"Resuscitation"},{"issue":"1","key":"262_CR128","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/glia.23216","volume":"66","author":"E van Tilborg","year":"2018","unstructured":"van Tilborg E, Achterberg EJM, van Kammen CM, van der Toorn A, Groenendaal F, Dijkhuizen RM et al (2018) Combined fetal inflammation and postnatal hypoxia causes myelin deficits and autism-like behavior in a rat model of diffuse white matter injury. Glia 66(1):78\u201393. https:\/\/doi.org\/10.1002\/glia.23216","journal-title":"Glia"},{"issue":"1","key":"262_CR129","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1111\/ejn.16040","volume":"58","author":"BY Luo","year":"2023","unstructured":"Luo BY, Zhou HS, Sun YF, Xiao QX, Chen L, She HQ et al (2023) The fate and prospects of stem cell therapy in the treatment of hypoxic-ischemic encephalopathy. Eur J Neurosci 58(1):2384\u20132405. https:\/\/doi.org\/10.1111\/ejn.16040","journal-title":"Eur J Neurosci"},{"key":"262_CR130","doi-asserted-by":"publisher","unstructured":"Mondal V, Ross-Munro E, Balasuriya GK, Kumari R, Hossen MM, Ageeli M et al (2025) A Comprehensive Review of the Pathophysiology of Neonatal Stroke and a Critique of Current and Future Therapeutic Strategies. Cells 14(12). https:\/\/doi.org\/10.3390\/cells14120910","DOI":"10.3390\/cells14120910"},{"issue":"2","key":"262_CR131","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/stcltm\/szab024","volume":"11","author":"L Zhou","year":"2022","unstructured":"Zhou L, McDonald C, Yawno T, Jenkin G, Miller S, Malhotra A (2022) Umbilical Cord Blood and Cord Tissue-Derived Cell Therapies for Neonatal Morbidities: Current Status and Future Challenges. Stem Cells Transl Med 11(2):135\u2013145. https:\/\/doi.org\/10.1093\/stcltm\/szab024","journal-title":"Stem Cells Transl Med"},{"key":"262_CR132","doi-asserted-by":"publisher","unstructured":"McDonald CA, Djuliannisaa Z, Petraki M, Paton MCB, Penny TR, Sutherland AE et al (2019) Intranasal Delivery of Mesenchymal Stromal Cells Protects against Neonatal Hypoxic(-)Ischemic Brain Injury. Int J Mol Sci 20(10). https:\/\/doi.org\/10.3390\/ijms20102449","DOI":"10.3390\/ijms20102449"},{"issue":"5","key":"262_CR133","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1113\/JP271104","volume":"594","author":"JD Aridas","year":"2016","unstructured":"Aridas JD, McDonald CA, Paton MC, Yawno T, Sutherland AE, Nitsos I et al (2016) Cord blood mononuclear cells prevent neuronal apoptosis in response to perinatal asphyxia in the newborn lamb. J Physiol 594(5):1421\u20131435. https:\/\/doi.org\/10.1113\/JP271104","journal-title":"J Physiol"},{"issue":"3","key":"262_CR134","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/sctm.20-0314","volume":"10","author":"JO Davidson","year":"2021","unstructured":"Davidson JO, van den Heuij LG, Fraser M, Wassink G, Miller SL, Lim R et al (2021) Window of opportunity for human amnion epithelial stem cells to attenuate astrogliosis after umbilical cord occlusion in preterm fetal sheep. Stem Cells Transl Med 10(3):427\u2013440. https:\/\/doi.org\/10.1002\/sctm.20-0314","journal-title":"Stem Cells Transl Med"},{"issue":"7","key":"262_CR135","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jcyt.2017.03.075","volume":"19","author":"B Oppliger","year":"2017","unstructured":"Oppliger B, Joerger-Messerli MS, Simillion C, Mueller M, Surbek DV, Schoeberlein A (2017) Mesenchymal stromal cells from umbilical cord Wharton\u2019s jelly trigger oligodendroglial differentiation in neural progenitor cells through cell-to-cell contact. Cytotherapy 19(7):829\u2013838. https:\/\/doi.org\/10.1016\/j.jcyt.2017.03.075","journal-title":"Cytotherapy"},{"issue":"2","key":"262_CR136","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/0271678X17729954","volume":"39","author":"LG van den Heuij","year":"2019","unstructured":"van den Heuij LG, Fraser M, Miller SL, Jenkin G, Wallace EM, Davidson JO et al (2019) Delayed intranasal infusion of human amnion epithelial cells improves white matter maturation after asphyxia in preterm fetal sheep. J Cereb Blood Flow Metab 39(2):223\u2013239. https:\/\/doi.org\/10.1177\/0271678X17729954","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"262_CR137","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1634\/stemcells.22-4-625","volume":"22","author":"K Bieback","year":"2004","unstructured":"Bieback K, Kern S, Kluter H, Eichler H (2004) Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22(4):625\u2013634. https:\/\/doi.org\/10.1634\/stemcells.22-4-625","journal-title":"Stem Cells"},{"key":"262_CR138","doi-asserted-by":"publisher","first-page":"981061","DOI":"10.3389\/fbioe.2022.981061","volume":"10","author":"A Papait","year":"2022","unstructured":"Papait A, Silini AR, Gazouli M, Malvicini R, Muraca M, O\u2019Driscoll L et al (2022) Perinatal derivatives: How to best validate their immunomodulatory functions. Front Bioeng Biotechnol 10:981061. https:\/\/doi.org\/10.3389\/fbioe.2022.981061","journal-title":"Front Bioeng Biotechnol"},{"key":"262_CR139","doi-asserted-by":"publisher","unstructured":"Dave C, Mei SHJ, McRae A, Hum C, Sullivan KJ, Champagne J et al (2022) Comparison of freshly cultured versus cryopreserved mesenchymal stem cells in animal models of inflammation: A pre-clinical systematic review. Elife 11. https:\/\/doi.org\/10.7554\/eLife.75053","DOI":"10.7554\/eLife.75053"},{"issue":"1","key":"262_CR140","doi-asserted-by":"publisher","first-page":"18078","DOI":"10.1038\/s41598-019-54462-x","volume":"9","author":"Y Tan","year":"2019","unstructured":"Tan Y, Salkhordeh M, Wang JP, McRae A, Souza-Moreira L, McIntyre L et al (2019) Thawed Mesenchymal Stem Cell Product Shows Comparable Immunomodulatory Potency to Cultured Cells In Vitro and in Polymicrobial Septic Animals. Sci Rep 9(1):18078. https:\/\/doi.org\/10.1038\/s41598-019-54462-x","journal-title":"Sci Rep"},{"issue":"6","key":"262_CR141","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/stmcls\/sxac025","volume":"40","author":"S Taghizadeh","year":"2022","unstructured":"Taghizadeh S, Chao CM, Guenther S, Glaser L, Gersmann L, Michel G et al (2022) FGF10 Triggers De Novo Alveologenesis in a Bronchopulmonary Dysplasia Model: Impact on Resident Mesenchymal Niche Cells. Stem Cells 40(6):605\u2013617. https:\/\/doi.org\/10.1093\/stmcls\/sxac025","journal-title":"Stem Cells"},{"issue":"5","key":"262_CR142","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/jcbfm.2013.3","volume":"33","author":"V Donega","year":"2013","unstructured":"Donega V, van Velthoven CT, Nijboer CH, Kavelaars A, Heijnen CJ (2013) The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment. J Cereb Blood Flow Metab 33(5):625\u2013634. https:\/\/doi.org\/10.1038\/jcbfm.2013.3","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"262_CR143","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/stcltm\/szae060","volume":"13","author":"YS Chang","year":"2024","unstructured":"Chang YS, Yang M, Ahn SY, Sung SI, Park WS (2024) Improving the future of clinical trials and translation of mesenchymal stromal cell therapies for neonatal disorders. Stem Cells Transl Med 13(10):941\u2013948. https:\/\/doi.org\/10.1093\/stcltm\/szae060","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"262_CR144","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1042\/CBI20110447","volume":"36","author":"X Zhang","year":"2012","unstructured":"Zhang X, Wang H, Shi Y, Peng W, Zhang S, Zhang W et al (2012) Role of bone marrow-derived mesenchymal stem cells in the prevention of hyperoxia-induced lung injury in newborn mice. Cell Biol Int 36(6):589\u2013594. https:\/\/doi.org\/10.1042\/CBI20110447","journal-title":"Cell Biol Int"},{"issue":"1","key":"262_CR145","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13287-024-03747-8","volume":"15","author":"EC Hermans","year":"2024","unstructured":"Hermans EC, Donega V, Heijnen CJ, de Theije CGM, Nijboer CH (2024) CXCL10 is a crucial chemoattractant for efficient intranasal delivery of mesenchymal stem cells to the neonatal hypoxic-ischemic brain. Stem Cell Res Ther 15(1):134. https:\/\/doi.org\/10.1186\/s13287-024-03747-8","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"262_CR146","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/stcltm\/szac004","volume":"11","author":"Z Weng","year":"2022","unstructured":"Weng Z, Wang Y, Ouchi T, Liu H, Qiao X, Wu C et al (2022) Mesenchymal Stem\/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies. Stem Cells Transl Med 11(4):356\u2013371. https:\/\/doi.org\/10.1093\/stcltm\/szac004","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"262_CR147","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/stmcls\/sxad014","volume":"41","author":"DF Doherty","year":"2023","unstructured":"Doherty DF, Roets L, Krasnodembskaya AD (2023) The Role of Lung Resident Mesenchymal Stromal Cells in the Pathogenesis and Repair of Chronic Lung Disease. Stem Cells 41(5):431\u2013443. https:\/\/doi.org\/10.1093\/stmcls\/sxad014","journal-title":"Stem Cells"},{"issue":"6","key":"262_CR148","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1164\/rccm.202310-1975OC","volume":"210","author":"C Cyr-Depauw","year":"2024","unstructured":"Cyr-Depauw C, Cook DP, Mizik I, Lesage F, Vadivel A, Renesme L et al (2024) Single-Cell RNA Sequencing Reveals Repair Features of Human Umbilical Cord Mesenchymal Stromal Cells. Am J Respir Crit Care Med 210(6):814\u2013827. https:\/\/doi.org\/10.1164\/rccm.202310-1975OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"262_CR149","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1164\/rccm.202403-0569OC","volume":"211","author":"C Cyr-Depauw","year":"2025","unstructured":"Cyr-Depauw C, Mizik I, Cook DP, Lesage F, Vadivel A, Renesme L et al (2025) Single-Cell RNA Sequencing to Guide Autologous Preterm Cord Mesenchymal Stromal Cell Therapy. Am J Respir Crit Care Med 211(3):391\u2013406. https:\/\/doi.org\/10.1164\/rccm.202403-0569OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"262_CR150","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s13287-025-04616-8","volume":"16","author":"T Azad","year":"2025","unstructured":"Azad T, Wu F, Mao J, Zhu J, Wang Y, Zhou X et al (2025) Exploring the therapeutic potential of MSC-derived secretomes in neonatal care: focus on BPD and NEC. Stem Cell Res Ther 16(1):476. https:\/\/doi.org\/10.1186\/s13287-025-04616-8","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"262_CR151","doi-asserted-by":"publisher","first-page":"e0164269","DOI":"10.1371\/journal.pone.0164269","volume":"11","author":"I Sammour","year":"2016","unstructured":"Sammour I, Somashekar S, Huang J, Batlahally S, Breton M, Valasaki K et al (2016) The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury. PLoS ONE 11(10):e0164269. https:\/\/doi.org\/10.1371\/journal.pone.0164269","journal-title":"PLoS ONE"},{"issue":"1","key":"262_CR152","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1038\/s41467-023-39958-5","volume":"14","author":"Y Gao","year":"2023","unstructured":"Gao Y, Chi Y, Chen Y, Wang W, Li H, Zheng W et al (2023) Multi-omics analysis of human mesenchymal stem cells shows cell aging that alters immunomodulatory activity through the downregulation of PD-L1. Nat Commun 14(1):4373. https:\/\/doi.org\/10.1038\/s41467-023-39958-5","journal-title":"Nat Commun"},{"key":"262_CR153","doi-asserted-by":"publisher","unstructured":"Behnke J, Kremer S, Shahzad T, Chao CM, Bottcher-Friebertshauser E, Morty RE et al (2020) MSC Based Therapies-New Perspectives for the Injured Lung. J Clin Med 9(3). https:\/\/doi.org\/10.3390\/jcm9030682","DOI":"10.3390\/jcm9030682"},{"issue":"1","key":"262_CR154","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13287-018-0903-4","volume":"9","author":"S Chaubey","year":"2018","unstructured":"Chaubey S, Thueson S, Ponnalagu D, Alam MA, Gheorghe CP, Aghai Z et al (2018) Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6. Stem Cell Res Ther 9(1):173. https:\/\/doi.org\/10.1186\/s13287-018-0903-4","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"262_CR155","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12916-025-04533-w","volume":"24","author":"Y Dong","year":"2025","unstructured":"Dong Y, Hadzic S, Leidner A, Marega M, Procida-Kowalski T, Bartkuhn M et al (2025) Prenatal lipopolysaccharide exposure programs the early-life lung development by modulating mesenchymal fibroblasts in a time- and dose-dependent manner. BMC Med 24(1):47. https:\/\/doi.org\/10.1186\/s12916-025-04533-w","journal-title":"BMC Med"},{"key":"262_CR156","doi-asserted-by":"publisher","unstructured":"Yamaguchi N, Horio E, Sonoda J, Yamagishi M, Miyakawa S, Murakami F et al (2024) Immortalization of Mesenchymal Stem Cells for Application in Regenerative Medicine and Their Potential Risks of Tumorigenesis. Int J Mol Sci 25(24). https:\/\/doi.org\/10.3390\/ijms252413562","DOI":"10.3390\/ijms252413562"},{"key":"262_CR157","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbrc.2022.03.044","volume":"605","author":"C Hao","year":"2022","unstructured":"Hao C, You J, Qiu H, Zhou O, Liu J, Zou W et al (2022) Hypoxic preconditioning improves the survival and pro-angiogenic capacity of transplanted human umbilical cord mesenchymal stem cells via HIF-1alpha signaling in a rat model of bronchopulmonary dysplasia. Biochem Biophys Res Commun 605:111\u2013118. https:\/\/doi.org\/10.1016\/j.bbrc.2022.03.044","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"262_CR158","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1161\/STROKEAHA.124.048964","volume":"56","author":"ST De Palma","year":"2025","unstructured":"De Palma ST, Hermans EC, Shamorkina TM, Trayford C, van Rijt S, Heck AJR et al (2025) Hypoxic Preconditioning Enhances the Potential of Mesenchymal Stem Cells to Treat Neonatal Hypoxic-Ischemic Brain Injury. Stroke 56(7):1872\u20131882. https:\/\/doi.org\/10.1161\/STROKEAHA.124.048964","journal-title":"Stroke"},{"issue":"4","key":"262_CR159","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jcyt.2020.01.009","volume":"22","author":"T Suzuki","year":"2020","unstructured":"Suzuki T, Sato Y, Yamamoto H, Kato T, Kitase Y, Ueda K et al (2020) Mesenchymal stem\/stromal cells stably transduced with an inhibitor of CC chemokine ligand 2 ameliorate bronchopulmonary dysplasia and pulmonary hypertension. Cytotherapy 22(4):180\u2013192. https:\/\/doi.org\/10.1016\/j.jcyt.2020.01.009","journal-title":"Cytotherapy"},{"issue":"3","key":"262_CR160","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/mt.2013.260","volume":"22","author":"CT van Velthoven","year":"2014","unstructured":"van Velthoven CT, Braccioli L, Willemen HL, Kavelaars A, Heijnen CJ (2014) Therapeutic potential of genetically modified mesenchymal stem cells after neonatal hypoxic-ischemic brain damage. Mol Ther 22(3):645\u2013654. https:\/\/doi.org\/10.1038\/mt.2013.260","journal-title":"Mol Ther"},{"key":"262_CR161","doi-asserted-by":"publisher","unstructured":"Rebelatto CLK, Boldrini-Leite LM, Daga DR, Marsaro DB, Vaz IM, Jamur VR et al (2023) Quality Control Optimization for Minimizing Security Risks Associated with Mesenchymal Stromal Cell-Based Product Development. Int J Mol Sci 24(16). https:\/\/doi.org\/10.3390\/ijms241612955","DOI":"10.3390\/ijms241612955"},{"key":"262_CR162","doi-asserted-by":"publisher","first-page":"645558","DOI":"10.3389\/fphar.2021.645558","volume":"12","author":"L Elowsson Rendin","year":"2021","unstructured":"Elowsson Rendin L, Lofdahl A, Kadefors M, Soderlund Z, Tykesson E, Rolandsson Enes S et al (2021) Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases. Front Pharmacol 12:645558. https:\/\/doi.org\/10.3389\/fphar.2021.645558","journal-title":"Front Pharmacol"},{"issue":"12","key":"262_CR163","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1089\/hum.2011.039","volume":"22","author":"MJ Hoogduijn","year":"2011","unstructured":"Hoogduijn MJ, Roemeling-van Rhijn M, Korevaar SS, Engela AU, Weimar W, Baan CC (2011) Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies. Hum Gene Ther 22(12):1587\u20131591. https:\/\/doi.org\/10.1089\/hum.2011.039","journal-title":"Hum Gene Ther"},{"key":"262_CR164","doi-asserted-by":"publisher","first-page":"1558301","DOI":"10.3389\/fped.2025.1558301","volume":"13","author":"L Bai","year":"2025","unstructured":"Bai L, Xin Y (2025) A bibliometric analysis of research trends in mesenchymal stem cell therapy for neonatal bronchopulmonary dysplasia: 2004\u20132024. Front Pediatr 13:1558301. https:\/\/doi.org\/10.3389\/fped.2025.1558301","journal-title":"Front Pediatr"},{"key":"262_CR165","doi-asserted-by":"publisher","first-page":"103913","DOI":"10.1016\/j.resp.2022.103913","volume":"302","author":"PM MacFarlane","year":"2022","unstructured":"MacFarlane PM, Mayer CA, Caplan AI, Raffay TM, Mayer AJ, Bonfield TL (2022) Human bone marrow-derived mesenchymal stem cells rescue neonatal CPAP-induced airway hyperreactivity. Respir Physiol Neurobiol 302:103913. https:\/\/doi.org\/10.1016\/j.resp.2022.103913","journal-title":"Respir Physiol Neurobiol"},{"issue":"3","key":"262_CR166","doi-asserted-by":"publisher","first-page":"L385","DOI":"10.1152\/ajplung.00389.2022","volume":"324","author":"MA Ransom","year":"2023","unstructured":"Ransom MA, Bunn KE, Negretti NM, Jetter CS, Bressman ZJ, Sucre JMS et al (2023) Developmental trajectory of extracellular vesicle characteristics from the lungs of preterm infants. Am J Physiol Lung Cell Mol Physiol 324(3):L385\u2013L92. https:\/\/doi.org\/10.1152\/ajplung.00389.2022","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"262_CR167","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1165\/rcmb.2021-0307OC","volume":"66","author":"ES Taglauer","year":"2022","unstructured":"Taglauer ES, Fernandez-Gonzalez A, Willis GR, Reis M, Yeung V, Liu X et al (2022) Antenatal Mesenchymal Stromal Cell Extracellular Vesicle Therapy Prevents Preeclamptic Lung Injury in Mice. Am J Respir Cell Mol Biol 66(1):86\u201395. https:\/\/doi.org\/10.1165\/rcmb.2021-0307OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"262_CR168","doi-asserted-by":"publisher","first-page":"L179","DOI":"10.1152\/ajplung.00329.2021","volume":"322","author":"AN Abele","year":"2022","unstructured":"Abele AN, Taglauer ES, Almeda M, Wilson N, Abikoye A, Seedorf GJ et al (2022) Antenatal mesenchymal stromal cell extracellular vesicle treatment preserves lung development in a model of bronchopulmonary dysplasia due to chorioamnionitis. Am J Physiol Lung Cell Mol Physiol 322(2):L179\u2013L90. https:\/\/doi.org\/10.1152\/ajplung.00329.2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"10","key":"262_CR169","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1164\/rccm.202012-4520OC","volume":"205","author":"MA Lithopoulos","year":"2022","unstructured":"Lithopoulos MA, Strueby L, O\u2019Reilly M, Zhong S, Mobius MA, Eaton F et al (2022) Pulmonary and Neurologic Effects of Mesenchymal Stromal Cell Extracellular Vesicles in a Multifactorial Lung Injury Model. Am J Respir Crit Care Med 205(10):1186\u20131201. https:\/\/doi.org\/10.1164\/rccm.202012-4520OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"262_CR170","doi-asserted-by":"publisher","first-page":"8791","DOI":"10.1038\/s41598-021-87706-w","volume":"11","author":"A Ali","year":"2021","unstructured":"Ali A, Zambrano R, Duncan MR, Chen S, Luo S, Yuan H et al (2021) Hyperoxia-activated circulating extracellular vesicles induce lung and brain injury in neonatal rats. Sci Rep 11(1):8791. https:\/\/doi.org\/10.1038\/s41598-021-87706-w","journal-title":"Sci Rep"},{"key":"262_CR171","doi-asserted-by":"publisher","first-page":"5784146","DOI":"10.1155\/2022\/5784146","volume":"2022","author":"S Obst","year":"2022","unstructured":"Obst S, Herz J, Alejandre Alcazar MA, Endesfelder S, Mobius MA, Rudiger M et al (2022) Perinatal Hyperoxia and Developmental Consequences on the Lung-Brain Axis. Oxid Med Cell Longev 2022:5784146. https:\/\/doi.org\/10.1155\/2022\/5784146","journal-title":"Oxid Med Cell Longev"},{"key":"262_CR172","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fphys.2019.00282","volume":"10","author":"C Sisa","year":"2019","unstructured":"Sisa C, Kholia S, Naylor J, Herrera Sanchez MB, Bruno S, Deregibus MC et al (2019) Mesenchymal Stromal Cell Derived Extracellular Vesicles Reduce Hypoxia-Ischaemia Induced Perinatal Brain Injury. Front Physiol 10:282. https:\/\/doi.org\/10.3389\/fphys.2019.00282","journal-title":"Front Physiol"},{"key":"262_CR173","doi-asserted-by":"publisher","unstructured":"Tscherrig V, Steinfort M, Haesler V, Surbek D, Schoeberlein A, Joerger-Messerli MS (2024) All but Small: miRNAs from Wharton\u2019s Jelly-Mesenchymal Stromal Cell Small Extracellular Vesicles Rescue Premature White Matter Injury after Intranasal Administration. Cells 13(6). https:\/\/doi.org\/10.3390\/cells13060543","DOI":"10.3390\/cells13060543"},{"key":"262_CR174","doi-asserted-by":"publisher","unstructured":"Vaes JEG, Onstwedder SM, Trayford C, Gubbins E, Maas M, van Rijt SH et al (2024) Modifying the Secretome of Mesenchymal Stem Cells Prolongs the Regenerative Treatment Window for Encephalopathy of Prematurity. Int J Mol Sci 25(12). https:\/\/doi.org\/10.3390\/ijms25126494","DOI":"10.3390\/ijms25126494"},{"key":"262_CR175","doi-asserted-by":"publisher","first-page":"1625787","DOI":"10.3389\/fmed.2025.1625787","volume":"12","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhu J, Ma Q, Zhou W, Yang L, Sheng S et al (2025) Trends in mesenchymal stem cell-derived extracellular vesicles clinical trials 2014\u20132024: is efficacy optimal in a narrow dose range? Front Med (Lausanne) 12:1625787. https:\/\/doi.org\/10.3389\/fmed.2025.1625787","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"262_CR176","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13287-023-03287-7","volume":"14","author":"A Lotfy","year":"2023","unstructured":"Lotfy A, AboQuella NM, Wang H (2023) Mesenchymal stromal\/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Res Ther 14(1):66. https:\/\/doi.org\/10.1186\/s13287-023-03287-7","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"262_CR177","doi-asserted-by":"publisher","first-page":"e12141","DOI":"10.1002\/jev2.12141","volume":"10","author":"A Tieu","year":"2021","unstructured":"Tieu A, Hu K, Gnyra C, Montroy J, Fergusson DA, Allan DS et al (2021) Mesenchymal stromal cell extracellular vesicles as therapy for acute and chronic respiratory diseases: A meta-analysis. J Extracell Vesicles 10(12):e12141. https:\/\/doi.org\/10.1002\/jev2.12141","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"262_CR178","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13287-022-02874-4","volume":"13","author":"D Zhu","year":"2022","unstructured":"Zhu D, Krause M, Yawno T, Kusuma GD, Schwab R, Barabadi M et al (2022) Assessing the impact of gestational age of donors on the efficacy of amniotic epithelial cell-derived extracellular vesicles in experimental bronchopulmonary dysplasia. Stem Cell Res Ther 13(1):196. https:\/\/doi.org\/10.1186\/s13287-022-02874-4","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"262_CR179","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/pr.2016.88","volume":"80","author":"YE Kim","year":"2016","unstructured":"Kim YE, Park WS, Sung DK, Ahn SY, Sung SI, Yoo HS et al (2016) Intratracheal transplantation of mesenchymal stem cells simultaneously attenuates both lung and brain injuries in hyperoxic newborn rats. Pediatr Res 80(3):415\u2013424. https:\/\/doi.org\/10.1038\/pr.2016.88","journal-title":"Pediatr Res"}],"container-title":["Molecular and Cellular Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-026-00262-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40348-026-00262-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-026-00262-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:21:32Z","timestamp":1791361292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40348-026-00262-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":179,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1186\/s40348-026-00262-z","relation":{},"ISSN":["2194-7791"],"issn-type":[{"value":"2194-7791","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"16 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"51"}}